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A formal definition of a prevalent cohort study is given by the statement, ''The prevalent cohort study consists of a sample of individuals who have a condition or disease at the time of enrollment in the study. These individuals are then followed over time to monitor endpoints such as disease progression or death'' (1, p. 106). The fact that a disease is not diagnosed at the actual onset has implications with regard to different forms of bias and the statistical methods used to analyze cohorts of this type.
Some medical conditions or infections are asymptomatic or only mildly symptomatic for a long time before sometimes turning into a more severe symptomatic disease, for example, infection with hepatitis C virus (HCV). As symptoms start to emerge, the probability of diagnosis increases. Consequently, a cohort of patients diagnosed with, for example, HCV will consist of individuals where the first period of infection is unobserved. The length of this unobserved period will vary between patients. Observations where the first time period is unobserved are named ''left-truncated data.'' When the time of infection is known or may be estimated, the analysis may take into account this differential entry into the cohort by choosing appropriate statistical models (2) . However, when the studied outcome in some way affects the timing of entry into the study cohort, this could lead to an analysis affected by selection bias.
As the influence of an imminent outcome on the probability of being included in the cohort is typically short lived, a common method for reducing the influence of selection bias is to exclude the first observation period for each individual after inclusion in the cohort (3). In practice, this means that observation time and events occurring during this time period are excluded from the statistical analysis. Patients in a more severe stage of the initial condition, already progressing toward the outcome of interest at the time of inclusion in the cohort, will thereby be removed from the study population. The proposed method aims to visualize this selection bias and to guide in the choice of time period for which personyears and events should be excluded.
The proposed method is applicable for cohorts in which individuals are included on the basis of conditions or states that are present and potentially detectable during a fairly long period of time and that do not invariably lead to inclusion immediately following the true onset-a prevalent cohort.
In situations where the effects of the studied disease or condition are immediate, such as death following an acute infection, the proposed method should not be used to identify selection bias. In this situation, other factors than selection bias may better explain the decreasing hazard immediately after inclusion in the cohort, the most obvious being that the risk of the studied event truly is higher soon after inclusion in the cohort. The graphs resulting from the proposed method must be interpreted with appropriate knowledge on the conditions studied and information on how individuals have been recruited into the cohort.
The method will be illustrated by using 2 different study cohorts: one cohort of patients diagnosed with monoclonal gammopathy of undetermined significance (MGUS) and one cohort of patients diagnosed with HCV. Both MGUS and HCV are conditions that are asymptomatic or mildly symptomatic for a long time before progressing into a more severe disease with increased morbidity and mortality (4, 5) . The outcomes studied were death in the MGUS cohort and hospitalizations for kidney-related disease in the HCV cohort.
Surveillance bias, that is, the increased surveillance and diagnosis for the studied outcome once patients are included in the cohort, may lead to an increased incidence and/or earlier diagnosis of the studied outcome. For the examples studied in this paper, surveillance bias is assumed to be negligible. The reason for this is that the outcomes studied are severe, likely to be diagnosed regardless of level of surveillance.
Other forms of bias associated with prevalent cohort studies are length-biased sampling and onset confounding (6) . These forms of bias should also be considered for prevalent cohorts but will not be discussed further here.
In discussions of confounding and selection bias, directed acyclic graphs may be used to graphically describe and analyze how selection bias enters a cohort study (7) (Figure 1 ). The objective is to study if the asymptomatic or mildly symptomatic disease (X) causes the outcome (Y). The disease X may cause Y either directly or by first developing into a more severe symptomatic stage (S) before progressing to Y. Only patients diagnosed with the disease (X) can enter a diagnosed cohort (D), which forms the basis for the study. Patients in the symptomatic stage of the disease (S) will more easily be identified and diagnosed as having X. This more frequent diagnosis of patients with symptomatic disease will lead to selection bias; that is, patients in D will not be representative of the total study base. In the situation described in the directed acyclic graph, we are interested in the relation whereby X causes Y (X / Y), either directly or over the symptomatic stage S. Conditioning on D, that is, being diagnosed with the condition X, which we must do because we may study only patients who have been diagnosed, opens a route from X to Y over the inverted fork D, leading to the selection bias described. Quantitative estimates of the risk of Y for patients with the disease X may be biased toward higher estimates because the population in D is not representative of the total population with X.
Other unknown or unmeasured common causes (here, named U) that both cause the outcome Y and lead to diagnosis of X (i.e., D ¼ 1) may introduce further selection bias into the analysis.
The processes described here should ideally be viewed as processes over time, something that may be quite complicated by using causal inference and directed acyclic graph theory. Selection bias caused by diagnosis of patients who have reached a symptomatic phase of the disease (S) may be dealt with by excluding patients who very soon after diagnosis of X reach the outcome Y. This will weaken the path between S and D. When the common cause U leading to the outcome Y and diagnosis of X (i.e., D ¼ 1) is an acute illness, the selection bias effect of this common cause is likely to be more pronounced just after diagnosis of the acute illness.
MATERIALS AND METHODS

Data
The proposed method will be illustrated by using 2 different data sets. The cohorts have been described elsewhere (8) (9) (10) and, in the examples presented here, details will be given as necessary for the statistical aspects of the examples.
MGUS cohort
We established a nationwide MGUS cohort by retrieving information on incident patients through a national network, Figure 1 . Directed acyclic graph theory can be used to describe in a formal way how selection bias may enter a cohort-based study. The objective is to study if the disease (X ) causes the outcome (Y ). Patients are often diagnosed with the disease (X ) when presenting with a symptomatic stage of the disease (S ) and are already progressing toward the outcome of interest (Y ). In an analysis not adjusting for S (symptoms) and conditioning on D (diagnosis of X ), a backdoor path is opened via S and D, and the analysis may be affected by selection bias. Additional selection bias may enter through unknown and unmeasured confounding factors (U ).
which included all in-and outpatient units from major hospital-based hematology/oncology centers in Sweden, diagnosed between 1965 and 2005. MGUS denotes the presence of monoclonal protein (M protein) on electrophoresis in patients without evidence of multiple myeloma, Waldenström macroglobulinemia, amyloidosis, or other lymphoproliferative disorders. MGUS is characterized by the following: a serum M protein concentration of less than 30 g/L; less than 10% clonal plasma cells in the bone marrow; little or no M protein in the urine; absence of lytic bone lesions; and no related anemia, hypercalcemia, or renal failure (11) .
The prevalence of MGUS is highly dependent on age; in people older than 70 years, the prevalence is estimated to be 5.3% (5) . Approximately 1%-1.5% of patients with MGUS progress yearly to multiple myeloma, Waldenström macroglobulinemia, amyloidosis, or other lymphoproliferative disorders. Because MGUS is asymptomatic, many patients are diagnosed either through random contact with the healthcare system, possibly because of other medical problems, or because they are seeking medical attention for emerging symptoms suggestive of multiple myeloma or related diseases.
The outcome studied in this example was whether patients with MGUS have an increased mortality compared with the general population, adjusting for age and sex, expressed as a standardized mortality ratio.
HCV infection cohort
The second example uses a cohort of individuals diagnosed with HCV infection and a matched reference cohort. The HCV cohort was gathered from the national surveillance database at the Swedish Institute for Infectious Disease Control and consisted of 43,000 patients diagnosed with HCV during the years 1990-2006. The matched reference cohort consisted of 215,000 individuals without HCV diagnosis (matching characteristics: birth year, sex, and county of residence) identified by Statistics Sweden (8) . For each subject in the HCV cohort, there were 5 matched control subjects who entered the analysis as controls at the same time point as their corresponding HCV subject. To avoid selection bias, we removed from the cohort everyone with a prior hospitalization related to kidney disease (irrespective of time frame) and all patients hospitalized (any condition) within the year prior to HCV diagnosis. After these precautions were taken, approximately 25,000 individuals from the HCV cohort remained for the analysis.
The prevalence of HCV infection in Sweden is estimated to be around 0.5%. The infection is often transmitted through intravenous drug use (about 65% of cases) and, before 1992, through blood transfusions (12) . The chronicity rate is about 75%, and the chronic infection is often asymptomatic with an increased risk of HCV-related complications, such as liver cirrhosis and hepatocellular carcinoma, after 20-30 years (4) . HCV has also been associated with non-Hodgkin lymphoma and chronic renal disease (13, 14) . HCV infection may be diagnosed as a result of screening of asymptomatic individuals in risk categories or because of medical problems, sometimes related to HCV.
The research question in this example is whether individuals with HCV are hospitalized more frequently because of kidney-related disease (including kidney cancer) compared with the control subjects. The planned analysis is a Cox regression.
Statistical method
The proposed method is based on modeling the hazard for the outcome studied on a continuous scale. In principle, almost any model for estimating the hazard of the outcome may be used. However, for the resulting graphs to be easily interpreted, the hazard should be modeled on a continuous time scale and the estimates need to be smoothed to reflect change over time rather than random fluctuations. It is therefore advantageous to use either a nonparametric model with a smoothing function or a flexible parametric model for the hazard. With use of a parametric model, the model needs to be flexible enough to adequately reflect the true shape of the underlying hazard. We have chosen to model the hazard using a restricted cubic spline model for survival data proposed by Royston and Parmar (15) .
The proposed model uses a restricted cubic spline function to model the cumulative hazard that is a more stable function than the hazard. The hazard is then derived by taking the derivative of the cumulative hazard function. The spline consists of cubic polynomials that are joined at ''knots.'' A spline with a larger number of polynomials (and many knots joining these polynomials) will give a more flexible cumulative hazard function. In currently available software, the number of knots may be set to between 2 and 10 knots (16). These knots are given default locations by dividing the uncensored logevent times equally over the corresponding polynomials. The spline function is restricted to having continuous ''zero-eth,'' first, and second derivatives, which will provide smooth joining of the polynomials. The fitted spline function is also forced to be linear in the tails, that is, beyond the lowest and highest knots. This stabilizes the function in the regions where the least data may be available, and this is particularly useful for our application because we are interested in the hazard immediately after inclusion in the cohort. As the components of the spline are cubic polynomials, a relatively small number of polynomials will give a highly flexible model.
Other advantages of this model are computational ease and the fact that the flexibility of the model may be varied by choosing a different number of knots for the baseline hazard, thereby investigating how sensitive any conclusions are to the parametric assumptions of the model. Because the objective is to study how the hazard changes over time, only a model with a flexible hazard could be used.
For the first example, the MGUS cohort, the proposed method will be compared with a standard method of investigating selection bias where the standardized mortality ratio is calculated separately for different time periods after inclusion in the cohort (17) .
For the second example, the shape of the modeled hazard for the HCV cohort will be compared with the shape of the hazard for the control group.
An increased hazard in the time period after inclusion in the cohort may be caused by selection bias; that is, patients with emerging symptoms of the outcome studied may be more prone to be recruited as members of the cohort. This will increase the hazard for the studied outcome immediately after inclusion in the cohort. Code to perform the calculations in STATA statistical software (StataCorp LP, College Station, Texas) is given in the Appendix.
RESULTS
MGUS cohort
The hazard is very high in the time period close to diagnosis of MGUS (Figure 2) . The hazard then rapidly declines to a minimum at approximately 1.5-2 years after diagnosis and then gradually increases again. The hazard for the MGUS cohort was modeled by using the restricted cubic spline model with the number of knots for the baseline hazard set to 2, 5, and 7. Other choices of number of knots gave similar results (not shown for visual clarity). Results for the model with 2 knots (solid line) may indicate that the 2-knot model is too rigid to adequately reflect the decreasing hazard with high enough sensitivity.
Using the same MGUS data set and calculating the standardized mortality ratio for disjointed consecutive time periods after MGUS diagnosis give the results shown in Figure 3 . The time periods for which the standardized mortality ratio was estimated were 0-6 months, >6-12 months, >12-18 months, >18-24 months, >2-5 years, and from >5 years until the end of follow-up. The standardized mortality ratio is higher during the first 3 time periods but reaches a minimum at 1.5-2 years. For the time periods >2-5 years and from >5 years until the end of follow-up, the observed standardized mortality ratios are higher.
Calculation of the standardized mortality ratio for disjointed intervals and modeling the baseline hazard by using a restricted cubic spline model to investigate selection bias would lead to the same result: The first 1.5-2 years of observation time should be excluded in an attempt to decrease the influence of selection bias.
HCV infection cohort
The hazards for the HCV cohort and the matched control group were modeled by using the restricted cubic spline model with 2, 3, and 4 knots, that is, fairly flexible models. Because interest was focused primarily on observing whether the hazard was increased in the first time period after diagnosis of hepatitis C, smaller random fluctuations occurring at later time points will not obscure the interpretation. Figure 4 clearly shows that the hazard for hospitalizations for kidneyrelated disease was excessively increased for the HCV cohort in the time period after HCV diagnosis (solid and dotted lines) but not for the matched control population (dashed line). The hazard was increased for approximately 12-24 months and then stabilized at a fairly constant level. For all time points, the hazard of the outcome studied was higher for the HCV cohort than for the control subjects, but it is only the very high decreasing hazard early after diagnosis of the HCV infection that may be due to selection bias. The graph indicates that it would be appropriate to remove at least 12-18 months of observation time to reduce the influence of selection bias.
DISCUSSION
Selection bias is a concern in cohort studies where the selection of patients into the cohort is somehow related to the probability of the outcome studied. Both of our examples show that these cohorts may be affected by considerable selection bias. Because of the asymptomatic or mildly symptomatic early phase of these conditions, patients are rarely diagnosed at the onset of the disease, when criteria for entering the cohort are first fulfilled, but rather at some later time point-either through screening when symptoms start to emerge or as a random finding when the patient is in contact with the health-care system for other medical problems.
In the MGUS example, other concurrent disease may be an important source of selection bias by acting as a common cause for the studied outcome (death) and diagnosis of the disease MGUS. The condition MGUS is usually diagnosed as a coincidental finding when patients are seeking medical attention for other health-care problems. These health-care problems may lead to an increased risk of the studied outcome in conjunction with the diagnosis of MGUS, thereby introducing selection bias (Figure 1 ). For the HCV example, the probable cause of selection bias is increased surveillance for HCVamong patients presenting with emerging kidney disease or other medical problems connected to the HCV infection.
Selection bias of the type described here is likely to be more pronounced shortly after inclusion in the cohort. After some time period, the health problems leading to inclusion in the cohort have either been resolved or resulted in the outcome studied. Therefore, removing observation time and events occurring shortly after inclusion in the cohort will reduce the impact of selection bias (3).
For patient populations identified through random screening, selection bias is a smaller concern because diagnosis in this setting is not likely to be connected to the severity of the disease. HCV is sometimes diagnosed through screening programs in risk populations but also because of emerging healthcare problems. For MGUS, there are no regular screening programs.
Standard methodology to adjust for selection bias in prevalent cohorts is to start observation of each individual at some time point after inclusion in the cohort. The appropriate time point may be judged by studying the incidence of the event of interest for several disjointed time intervals after inclusion in the cohort. If the incidence is higher in the time period immediately after inclusion in the cohort, this may indicate selection bias. This established standard method has some drawbacks. The method relies on dividing the observation time after inclusion in the cohort into disjointed time intervals. How these intervals are chosen may influence the analysis. If the intervals are short, the number of the studied outcomes in each interval may be low and the precision of risk estimates for each interval poor. If longer intervals are formed, it may be difficult to identify the shortest time to be excluded from the analysis.
A recently proposed method, cumulative standardized incidence ratio, partly solves the problems associated with fixed-time intervals and low precision of short intervals for register-based studies with few events (18) . A limitation of this method is that the incidence of the studied outcome is assumed to reach a steady level or plateau after some initial time period. For a cohort where the risk of the studied outcome increases considerably with time, such as in the MGUS cohort discussed, the method of cumulative standardized incidence ratio should not be used because the method may fail to identify the first time period affected by selection bias. The reason for failure is the cumulative nature of this method, where the initial time period (possibly affected by selection bias) is evaluated together with the follow-up time. When the risk of the studied outcome increases with follow-up time, the selection bias may become invisible. The proposed method of modeling the hazard on a continuous scale addresses this problem and, for the MGUS example, the decrease in hazard after the initial time period affected by selection bias is clearly visible, although the hazard increases fairly steeply with observation time.
Use of a statistical model always involves relying on the underlying assumptions, in this case, the choice of number of knots for the baseline hazard. Both examples presented are shown with different choices for the number of knots of the baseline hazard. A reasonable approach is to model the hazard by using a few models with different numbers of knots. The models using a ''sufficient'' number of knots should give concordant results. In the MGUS example, the models with 5 and 7 knots give the same result; the minimum hazard is reached after approximately 1.5 years. The model with 2 knots may not be flexible enough and should be discarded. For the HCV example, the models with 3 knots and 5 knots give very similar results. A model with 2 knots proved to be too rigid (not shown). The use of models with a higher number of knots increases the flexibility of the baseline hazard. The objective is to find the minimum hazard after inclusion in the cohort, and choosing a very flexible model may reflect random noise rather than modeling the overall change in hazard. The key to successful modeling is understanding the data and investigating several options, thereby investigating the sensitivity of any conclusions to the underlying modeling assumptions. The MGUS example shows that the proposed method gives results very similar to a standard approach, calculating the standardized mortality ratio for several disjointed time intervals (Figure 2) .
Interestingly, for the HCV cohort example, great precaution had already been taken to avoid selection bias before modeling the hazard shown in Figure 3 . All patients hospitalized the year prior to HCV diagnosis or with any prior hospitalization related to kidney disease had been removed from the cohort. Nevertheless, the hazard decreased for approximately 1 year to later stabilize and slightly increase with follow-up time. At all time points, the hazard was considerably higher for the HCV cohort compared with that for the control group. In addition to visualization of selection bias, the graph gives information on the validity of the proportional hazards assumption needed for Cox regression. In this example, this assumption is clearly reasonable for all time points after 12 months.
Sometimes a slowly decreasing hazard in the cohort is caused by frailty effects; the most susceptible individuals are affected by the studied complication early in the disease, thereby gradually depriving the cohort of the most vulnerable individuals. The resultant change in hazard is usually a slow, gradual decrease, in contrast to hazard related to selection bias, which often decreases in shorter time frames. In a cohort with frailty and selection bias, the changes in hazard may appear as a biphasic curve, steeper in the early time period after inclusion in the cohort. Albeit difficult to judge how to handle this situation statistically, the graph provides valuable information on both selection bias and possible frailty effects.
When the planned analysis is Cox regression, the proposed method of modeling hazard as a function of inclusion in the cohort may be particularly useful. Calculating the hazard ratio for different choices of time of entry into the study may give results that are difficult to interpret. This would be especially true in more complex models with time-dependent covariates where other factors may account for the change in observed hazard ratios. In addition, when the planned analysis is Cox regression, a cohort of unexposed individuals will be available for comparison. For the unexposed individuals, the ''date of diagnosis'' is unrelated to the outcome, and no hazard changes in specific relation to this date would be expected.
In general, the importance of an observed selection bias, if not corrected for by excluding observation time and events, will depend on several factors; the most obvious is the magnitude of the observed bias. The choice of statistical method is also important. For cumulative measures, such as the standardized incidence ratio, the length of follow-up of the cohort will influence the impact of an observed selection bias. If the follow-up period is long, for example, many years, an observed bias, although very pronounced, may be diluted to become almost insignificant. The same factors that will determine the impact of selection bias, if not corrected for, will also influence the impact of different choices for cutoff. The proposed method does not offer any standard algorithm for deciding upon an exact cutoff, and sometimes several choices are possible, especially when the hazard is declining very slowly. In this situation, the exact choice also has very little impact. For the HCV example, the hazard decreases rapidly during the first year, but there is a further slight decline in hazard during the second year. In deciding on an appropriate cutoff for this cohort, one should investigate the impacts of the different choices by calculating the hazard ratios for a few reasonable cutoffs (e.g., 12, 18, and 24 months). If the calculated hazard ratio varies for the different cutoffs, the longer cutoff would be advocated to avoid a biased estimate.
On a clinical note, a few important aspects have to be kept in mind when interpreting results based on cohorts of patients diagnosed in standard clinical practice. For example, although there are comments to be made regarding selection bias and issues related to undetected early disease, they are yet representative of patients with that particular condition who come to attention in clinical medicine. Taken together, for studies designed to uncover the etiology and biologic underpinnings of pathogenesis, screening studies are ideal in that they define patients who are independent of underlying comorbidities and medical history and allow the application of molecular epidemiology studies using defined assays on stored samples. On the other hand, clinically defined cohorts of patients are representative of patients in the community, and they allow investigations designed to characterize patterns of morbidity and mortality in a clinical context.
The proposed method is suitable to investigate selection bias in cohort studies of an initially asymptomatic medical condition or infectious disease that could then or subsequently cause the outcome of interest. In a situation where there is an acute infection or initiating event (e.g., influenza) leading to an immediate increased risk of some event, the proposed method is not suitable.
In conclusion, modeling the hazard for an outcome of interest in a cohort study can provide useful information on the hazard in the time period after diagnosis of the initial condition or infection. If the hazard is increased initially and decreases with follow-up time, this may indicate selection bias. The time period for which the hazard is increased provides guidance on which time window for exclusion of person-years and events should be used.
